Co-Delivery of Curcumin and Paclitaxel by "Core-Shell" Targeting Amphiphilic Copolymer to Reverse Resistance in the Treatment of Ovarian Cancer.

Meng-Dan ZhaoJun-Qin LiFeng-Ying ChenWei DongLi-Juan WenWei-Dong FeiXiao ZhangPei-Lei YangXin-Mei ZhangCai-Hong Zheng

Published in: International journal of nanomedicine (2019)

This special structure of targeting nanoparticles co-delivery with the curcumin and paclitaxel can increase the anti-tumor efficacy without increasing the adverse reactions as a promising strategy for therapy ovarian cancer.

Keyphrases

cancer therapy
drug delivery
combination therapy
bone marrow
chemotherapy induced
adverse drug